Lilly migraine drug wins European panel thumbs-up
A European Medicines Agency panel on Friday recommended the approval of U.S. pharmaceutical group Eli Lilly's migraine treatment, bringing the drug one step closer to being sold in the European Union.
from Reuters: Health News https://reut.rs/2QOxH7a
http://bit.ly/2zwRqiM